• 1
    Bergström J & Lindholm B. Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare? Kidney Int 1993; 34: S39 S50.
  • 2
    Shaldon S, Koch KM, Dinarello CA. Interleukin-1 activation and acute phase response during hemodialysis. Contrib Nephrol 1988; 61: 18 26.
  • 3
    Cederholm T, Wretlind B, Hellström K et al. Enhanced generation of interleukins 1β and 6 may contribute to the cachexia of chronic disease. Am J Clin Nutr 1997; 65: 876 82.
  • 4
    Bergström J & Lindholm B. Malnutrition, cardiac disease and mortality: an integrated point of view. Am J Kidney Dis 1998; 32: 1 10.
  • 5
    Pereira BJG, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA. Plasma levels of IL-1β, TNF-α and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 1994; 45: 890 6.
  • 6
    Aguilera A, Codoceo R, Selgas R et al. Anorexigen (TNF-α, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD): their relationship with nutritional parameters. Nephrol Dial Transpl 1998; 13: 1476 83.
  • 7
    McKenna RM, MacDonald C, Bernstein KN, Rush DN. Increased production of tumor necrosis factor activity by hemodialysis but not peritoneal dialysis patients. Nephron 1994; 67: 190 6.
  • 8
    Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris GK. Tumor necrosis factor-α in severe congestive cardiac failure. Br Heart J 1993; 70: 141 3.
  • 9
    Levine B, Kalman J, Mayer L, Fillit H, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236 41.
  • 10
    Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-α levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150: 1453 5.
  • 11
    Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456 62.
  • 12
    Giatras I, Lau J, Levey AS. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. Ann Intern Med 1997; 127: 337 45.
  • 13
    Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled study. Ann Int Med 1998; 128: 982 8.
  • 14
    The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685 91.
  • 15
    CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the north Scandinavian enalapril survival study. N Engl J Med 1987; 316: 1429 35.
  • 16
    Schindler R, Dinarello CA, Koch KM. Angiotensin-converting-enzyme inhibitors suppress synthesis of tumor necrosis factor and interleukin 1 by human peripheral blood mononuclear cells. Cytokine 1995; 7: 526 33.
  • 17
    Anderson P, Cederholm T, Palmblad J. Captopril reduces TNF-α induced IL-1β synthesis in human peripheral blood monocytes (Abstract). J Invest Med 1998; 46: 196A.
  • 18
    Fukuzawa M, Satoh J, Sagara M et al. Angiotensin-converting enzyme inhibitors suppress production of tumor necrosis factor-alpha in vitro and in vivo. Immunopharmacology 1997; 36: 49 55.
  • 19
    Peeters AC, Netea MG, Kullberg BJ, Thien T, Van Der Meer JW. The effect of renin-angiotensin inhibitors on pro- and anti-inflammatory cytokine production. Immunology 1998; 94: 376 9.
  • 20
    Stenvinkel P, Heimbürger O, Tuck C, Berglund L. Apo (a) isoform size, nutritional status and inflammatory markers in chronic renal failure. Kidney Int 1998; 53: 1336 42.
  • 21
    Baker JP, Detsky AS, Wesson DE et al. Nutritional assessment: a comparison of clinical judgment and objective measurements. N Engl J Med 1982; 306: 969 72.
  • 22
    Plata-Salamán CR. Cytokines and anorexia: a brief overview. Seminars Oncol 1998; 25: 64 72.